Theratechnologies Stock Filter Stocks by Fundamentals
| THTX Stock | USD 1.20 0.01 0.83% |
Theratechnologies fundamentals help investors to digest information that contributes to Theratechnologies' financial success or failures. It also enables traders to predict the movement of Theratechnologies Stock. The fundamental analysis module provides a way to measure Theratechnologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theratechnologies stock.
Theratechnologies | Shares Owned by Institutions |
Theratechnologies Current Valuation Drivers
We derive many important indicators used in calculating different scores of Theratechnologies from analyzing Theratechnologies' financial statements. These drivers represent accounts that assess Theratechnologies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Theratechnologies' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 709.8M | 1.2B | 831.6M | 41.7M | 37.6M | 35.7M | |
| Enterprise Value | 752.5M | 1.3B | 874.4M | 66.6M | 59.9M | 56.9M |
Theratechnologies Institutional Holders
Institutional Holdings refers to the ownership stake in Theratechnologies that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Theratechnologies' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Theratechnologies' value.| Shares | Bare Financial Services Inc | 2024-09-30 | 26.8 K | Beacon Pointe Advisors, Llc | 2024-06-30 | 26.5 K | Geode Capital Management, Llc | 2024-06-30 | 25.7 K | Bank Of Montreal | 2024-06-30 | 18.3 K | Bmo Capital Markets Corp. | 2024-06-30 | 18.3 K | Ubs Group Ag | 2024-06-30 | 17.5 K | Kohmann Bosshard Financial Services, Llc | 2024-09-30 | 15.4 K | Greatmark Investment Partners Inc | 2024-09-30 | 14.9 K | Modern Wealth Management Llc | 2024-09-30 | 11 K | Nantahala Capital Management, Llc | 2024-06-30 | 5.4 M | Soleus Capital Management, L.p. | 2024-06-30 | 4.8 M |
Theratechnologies Fundamentals
| Return On Equity | -11.17 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | 0.27 % | ||||
| Current Valuation | 74.25 M | ||||
| Shares Outstanding | 45.98 M | ||||
| Shares Owned By Insiders | 1.22 % | ||||
| Shares Owned By Institutions | 51.56 % | ||||
| Number Of Shares Shorted | 43.03 K | ||||
| Price To Book | 20.13 X | ||||
| Price To Sales | 0.66 X | ||||
| Revenue | 81.76 M | ||||
| Gross Profit | 56.22 M | ||||
| EBITDA | (10.31 M) | ||||
| Net Income | (23.96 M) | ||||
| Cash And Equivalents | 36.46 M | ||||
| Cash Per Share | 0.38 X | ||||
| Total Debt | 58.97 M | ||||
| Debt To Equity | 5.62 % | ||||
| Current Ratio | 1.04 X | ||||
| Book Value Per Share | (0.43) X | ||||
| Cash Flow From Operations | (5.68 M) | ||||
| Short Ratio | 0.95 X | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 5.26 | ||||
| Number Of Employees | 103 | ||||
| Beta | 1.73 | ||||
| Market Capitalization | 55.64 M | ||||
| Total Asset | 77.77 M | ||||
| Retained Earnings | (408.66 M) | ||||
| Working Capital | 16 M | ||||
| Net Asset | 77.77 M |
About Theratechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Theratechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Theratechnologies Stock Analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.